Biopharma, medical tech and life sciences-focused 5AM Ventures has raised $750m across a new pair of funds targeting startups across the early and late-stage of investment.
The post 5AM Ventures ups fundraising ante with $750m across new flagship, later-stage funds first appeared on AltAssets Private Equity News.
